Navigation Links
OPC Connectivity Between TruBio Software and Nova FLEX Analyzers

SANTA CLARA, Calif., March 5 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio(TM) plug-in for OPC connectivity between TruBio control software and Nova FLEX(TM) analyzers. OPC is the de facto standard for data exchange between process control systems and different hardware platforms.

OPC-based communication between a FLEX and TruBio reduces errors or time delays of manual sampling, and provides automated reporting of results. More sophisticated process control strategies can be implemented, process parameters can be adjusted without human intervention, and, when process alarm conditions occur, off-site personnel can be alerted and/or automatic corrective action be taken. Additionally, all off-line FLEX data can be directly consolidated into the TruBio/DeltaV historian, or used in automated batch report generation for electronic records.

Basil Zimmo, Vice President of Software at Finesse, stated, "The Nova FLEX-TruBio plug-in will reduce operating costs: printouts of standalone analyzer results will no longer have to be manually attached or tracked. Furthermore, this product will improve bioprocess quality and yield: programming a Nova FLEX to automatically standardize an in-situ probe or using FLEX cell viability data in real-time algorithms will increase the accuracy and repeatability of control."

"By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability, thereby allowing our customers real-time benefits that, until now, were impossible," said a Nova Biomedical spokesperson.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.

SOURCE Finesse Solutions, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. PCAS : Tighter Links Between PCAS and Proteus
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
8. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
9. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
10. IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea
11. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
Post Your Comments:
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)...  Amgen (NASDAQ: AMGN ) today announced ... life sciences incubator to accelerate the development of new ... at QB3@953 was created to help high-potential life science ... early stage organizations - access to laboratory infrastructure. ... two "Amgen Golden Ticket" awards, providing each winner with ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):